Patent details

Basic Information

Publication number:

EP2187743

PCT Application Number:

PCT/US/2008/073520

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP088273628

PCT Publication Number:

WO/2009/023877

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Rapamycin formulations for treatment of age related macular degeneration

French Title of Invention:

Formulations de rapamycine pour le traitement de la dégénérescence maculaire liée à l'âge

German Title of Invention:

Rapamycinformulierungen zur Behandlung der altersbedingten Makuladegeneration

SPC Number:

Dates

Filing date:

18/08/2008

Grant date:

30/07/2014

EP Publication Date:

30/07/2014

PCT Publication Date:

19/02/2009

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

26/05/2010

EP B1 Publication Date:

30/07/2014

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

18/08/2014

Expiration date:

18/08/2028

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

18/08/2008

 

 

Name:

Santen Pharmaceutical Co. Ltd

Address:

9-19, Shimoshinjo 3-chome Higashiyodogawa-ku, Osaka 533-8651, Japan (JP)

Inventor

1

Name:

FAROOQ Sidiq

Address:

United States (US)

2

Name:

TAKHAR Sudeep, Kaur

Address:

United States (US)

3

Name:

NIVAGGIOLI Thierry

Address:

United States (US)

4

Name:

MUDUMBA Sreenivasu

Address:

United States (US)

5

Name:

DOR Philippe, Jm

Address:

United States (US)

6

Name:

WEBER David, A.

Address:

United States (US)

Priority

1

Priority Number:

965282 P

Priority Date:

16/08/2007

Priority Country:

United States (US)

2

Priority Number:

965258 P

Priority Date:

16/08/2007

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 9/00;

Filing date	Document type	Number of pages